JP2003529550A5 - - Google Patents

Download PDF

Info

Publication number
JP2003529550A5
JP2003529550A5 JP2001527772A JP2001527772A JP2003529550A5 JP 2003529550 A5 JP2003529550 A5 JP 2003529550A5 JP 2001527772 A JP2001527772 A JP 2001527772A JP 2001527772 A JP2001527772 A JP 2001527772A JP 2003529550 A5 JP2003529550 A5 JP 2003529550A5
Authority
JP
Japan
Prior art keywords
group
liposome
cationic compound
vaccine
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2001527772A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003529550A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2000/003773 external-priority patent/WO2001024773A1/en
Publication of JP2003529550A publication Critical patent/JP2003529550A/ja
Publication of JP2003529550A5 publication Critical patent/JP2003529550A5/ja
Ceased legal-status Critical Current

Links

JP2001527772A 1999-10-01 2000-10-02 リポソーム封入されたdna経口ワクチン Ceased JP2003529550A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99307786 1999-10-01
EP99307786.6 1999-10-01
PCT/GB2000/003773 WO2001024773A1 (en) 1999-10-01 2000-10-02 Liposome-entrapped dna oral vaccines

Publications (2)

Publication Number Publication Date
JP2003529550A JP2003529550A (ja) 2003-10-07
JP2003529550A5 true JP2003529550A5 (cg-RX-API-DMAC7.html) 2007-12-06

Family

ID=8241653

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001527772A Ceased JP2003529550A (ja) 1999-10-01 2000-10-02 リポソーム封入されたdna経口ワクチン

Country Status (11)

Country Link
US (1) US7008791B1 (cg-RX-API-DMAC7.html)
EP (1) EP1217989B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003529550A (cg-RX-API-DMAC7.html)
KR (1) KR100744237B1 (cg-RX-API-DMAC7.html)
CN (1) CN1196474C (cg-RX-API-DMAC7.html)
AT (1) ATE312599T1 (cg-RX-API-DMAC7.html)
AU (1) AU7540500A (cg-RX-API-DMAC7.html)
CA (1) CA2386024A1 (cg-RX-API-DMAC7.html)
DE (1) DE60024843T2 (cg-RX-API-DMAC7.html)
ES (1) ES2256043T3 (cg-RX-API-DMAC7.html)
WO (1) WO2001024773A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4294584B2 (ja) 2002-07-05 2009-07-15 リポクセン・テクノロジーズ・リミテツド 核酸ワクチン接種の免疫応答を高めるための方法
WO2004100928A1 (de) * 2003-05-09 2004-11-25 Novosom Ag Injizierbare liposomale depots zum wirkstoffdelivery
JP4255396B2 (ja) * 2004-03-19 2009-04-15 津田駒工業株式会社 水噴射式織機の水受け装置
CA2687208C (en) * 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems
AU2008227852B2 (en) * 2007-03-19 2011-02-24 Fresenius Kabi Oncology Ltd. Proliposomal and liposomal compositions
CN101940321B (zh) * 2010-08-06 2012-06-20 南昌大学 动态高压微射流-冻融法制备中链脂肪酸纳米脂质体
CN101940320B (zh) * 2010-08-06 2012-08-29 南昌大学 薄膜分散-动态高压微射流制备中链脂肪酸纳米脂质体
EP2708134A1 (en) 2012-09-17 2014-03-19 Unilever N.V. Dough compositions comprising a structured fat phase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938298B1 (en) 1996-09-13 2002-12-04 Lipoxen Technologies Limited Liposome-based composition
FR2760193B1 (fr) * 1997-02-28 1999-05-28 Transgene Sa Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules

Similar Documents

Publication Publication Date Title
US5830430A (en) Cationic lipids and the use thereof
KR100507660B1 (ko) 리포좀
DE60310562T2 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
JPS6238330B2 (cg-RX-API-DMAC7.html)
EP0722338B1 (en) Protein- or peptide-cochleate vaccines and methods of immunizing using the same
JP2997073B2 (ja) 鼻腔内または吸入投与用ワクチン製剤およびその製造方法
JP2021522163A5 (cg-RX-API-DMAC7.html)
JP2005525992A (ja) 生物学的物質を充填した小胞の調製法およびそれらの様々な使用
US20130108688A1 (en) Delivery of H2 Antagonists
WO1998053799A9 (en) Immunogenic compositions
US7008791B1 (en) Liposome-entrapped DNA oral vaccines
MX2008010107A (es) Vehiculo de vacuna novedoso.
ES2576851T3 (es) Composiciones vacunales a base de sticholisina encapsuladas en llposomas
Wilschut et al. Liposomes as a mucosal adjuvant system: an intranasal liposomal influenza subunit vaccine and the role of IgA in nasal anti-influenza immunity
WO2003000232A2 (en) Method for preparation of vesicles loaded with immunostimulator y oligodeoxynucleotides
Alves et al. Ovalbumin encapsulation into liposomes results in distinct degrees of oral immunization in mice
JPH09501168A (ja) 生物構造体、生体ポリマー及び/又はオリゴマーを充填した小胞の調製方法
Tan et al. A Novel Positively-Charged Lipid 1, 2-Bis (Hexadecylcycloxy)-3-Trimethyl aminopropane (BisHOP) Enhances the Adjuvant Effect of Liposomes on Encapsulated Tetanus Toxoid
CA2022033A1 (en) Method for combining a mixture of heterogeneous substances with liposomes
Tan A study of the efficacy of liposomes in comparison to new and established adjuvants in potentiating the antibody response against hepatitis B virus surface antigen
JPWO1993020801A1 (ja) リポソーム組成物
Yang Liposome-based subunit and DNA hepatitis B vaccines
Kersten et al. Antigen Carriers: A Success Determining Factor for Subunit Vaccines?
JP2004161781A (ja) 経口ワクチン